Academic Partnerships Ona actively collaborates with academics and clinicians to discover novel ADC targets, presenting sales opportunities for sponsored research, discovery services, and co-development programs with biotech partners and contract research organizations.

Funding Momentum Recent financing rounds indicate growth and resource availability, creating demand for clinical development support, GMP manufacturing partnerships, and regulatory and commercial planning services to advance ADC programs.

Leadership Growth New board leadership and executive appointments signal a growth-focused governance stance and openness to strategic alliances; this creates openings to engage strategic partners, investors, and advisory services to align on pipelines.

ADC Capabilities First-in-class ADC development implies needs across discovery, preclinical testing, toxicology, manufacturing, and early-phase clinical development; opportunities to offer discovery collaborations, antibody engineering, ADC conjugation, toxicology studies, and GMP-CMC support.

European Presence Based in Barcelona with a European footprint and active regional funding, opportunities to partner on EU oncology programs, regional clinical trials, and EMA/regulatory support with Spain and broader Europe.